Mereo BioPharma Announces Appointment of Pierre Jacquet, M.D., Ph.D. to Board of Directors

NEXT STORY
This Magic Mushroom Day, Communities Across the Globe Celebrate the Transformative Healing Power of Using Psychedelics as Medicine
PREV STORY
OSE Immunotherapeutics Presented Positive Final Results of Tedopi® Phase 3 Clinical Trial in Secondary Resistant Non-Small Cell Lung Cancer Patients at the European Society for Medical Oncology (ESMO) Virtual Congress 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MyoKardia Announces Appointment of June Lee, M.D., as Chief Operating Officer and Radhika Tripuraneni, M.D., as Vice President, Medical Affairs

SOUTH SAN FRANCISCO, Calif., Feb. 01, 2017 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a ...

author_avatar
NASDAQ Market News

MPI – FDA approves OVs IDE and IND for ovarian cancer with its PARP inhibitor and DRP

Hoersholm, Denmark, August 27, 2018 - Medical Prognosis Institute A/S and Oncology Venture AB ...

author_avatar
NASDAQ Market News

NGM Discloses Third Oncology Development Candidate, NGM438, a Novel Antagonist Antibody Inhibiting LAIR1 for the Treatment of Advanced Solid Tumors

author_avatar
NASDAQ Market News